Tegoprazan Impurity 123 CAS CATO-C4X-2297123
| CAS No. | CATO-C4X-2297123 |
| Molecular Formula | - |
| Molecular Weight | 376.37 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Based on its molecular formula C19H14D3F2N3O3, Tegoprazan Impurity 123 contains deuterium isotope labeling, a steroid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 376.37 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
CATO supplies Tegoprazan Impurity 123 (CAS CATO-C4X-2297123), a pharmacopoeial impurity reference standard (molecular formula C19H14D3F2N3O3, MW 376.37 g/mol) used for the identification and quantification of trace impurities in APIs.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C19H14D3F2N3O3 |
| Molecular Weight | 376.37 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 13.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Tegoprazan Standards
- Tegoprazan Impurity 17 (CAS 942195-86-0)
- Tegoprazan Impurity 73 (CAS CATO-C4X-229773)
- Tegoprazan impurity 86 (CAS CATO-C4X-229786)
- Tegoprazan Impurity 122 (CAS 2351939-46-1)
- Tegoprazan Impurity 135 (CAS CATO-C4X-2297135)
- Tegoprazan impurity 32 (CAS CATO-C4X-229732)
- Tegoprazan impurity 39 (CAS CATO-C4X-229739)
- Tegoprazan Impurity 96 (CAS CATO-C4X-229796)
Recommended Standards
- N-Nitroso Nafamostat impurity 92 (CAS CATO-C4X-133292)
- Thiencarbazone (CAS 936331-72-5)
- N-Nitroso Nafamostat impurity 120 (CAS CATO-C4X-1332120)
- Antofloxacin (CAS 119354-43-7)
- Atorvastatin Impurity 95 (CAS 442851-50-5)
- Ceftriaxone Impurity 21 (CAS CATO-C4X-116321)
- Lurasidone Impurity 68 (CAS CATO-C4X-102868)
- 3-Amino-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid (CAS 1368200-78-5)
- [2-(2-aminoethoxy)phenyl]methanamine dihydrochloride (CAS 1803588-13-7)
- (E)-[(2-{[(4-chlorophenyl)methyl]sulfanyl}quinolin-3-yl)methylidene][(4-methoxyphenyl)methoxy]amine (CAS 478065-90-6)
- (S)-1,3-Dibenzylpiperazine (CAS 204327-96-8)
- N-(4-amino-3-methylphenyl)-2,2,2-trifluoroacetamide (CAS 1349718-37-1)
- 7-Bromo-2H-pyrazolo[3,4-b]quinolin-3-amine (CAS 1017465-30-3)
- Acetyl-(Leu28·31)-Neuropeptide Y (24-36) (CAS 155709-24-3)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com